Oryzon Genomics, S.A. announced that Dr. Ana Limón has been appointed as Senior Vice President of Clinical Development and Global Medical Affairs. This appointment strengthens the company's permanent presence in the US as the company builds out strategic partnerships with US hospitals and research institutions to develop its pipeline and clinical programs. Dr. Limón's broad scientific and clinical research experience in hematology and oncology will be key in developing the company's clinical programs. She joins the company from Deciphera Pharmaceuticals.